78 66

Cited 25 times in

Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice

 Ali Amin  ;  Soo-kyoung Choi  ;  Maria Galan  ;  Modar Kassan  ;  Megan Partyka  ;  Philip Kadowitz  ;  Daniel Henrion  ;  Mohamed Trebak  ;  Souad Belmadani  ;  Khalid Matrougui 
 JOURNAL OF PATHOLOGY, Vol.227(2) : 165-174, 2012 
Journal Title
Issue Date
Animals ; Anti-Inflammatory Agents/pharmacology* ; Biomarkers/blood ; Blood Vessels/drug effects* ; Blood Vessels/immunology ; Blood Vessels/metabolism ; Blood Vessels/pathology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy* ; Diabetes Mellitus, Type 2/immunology ; Diabetes Mellitus, Type 2/pathology ; Diabetic Angiopathies/blood ; Diabetic Angiopathies/etiology ; Diabetic Angiopathies/immunology ; Diabetic Angiopathies/pathology ; Diabetic Angiopathies/prevention & control* ; Disease Models, Animal ; Endoplasmic Reticulum/drug effects* ; Endoplasmic Reticulum/immunology ; Endoplasmic Reticulum/metabolism ; Endoplasmic Reticulum/pathology ; Endoplasmic Reticulum Stress/drug effects* ; Hindlimb ; Interleukin 1 Receptor Antagonist Protein/pharmacology* ; Ischemia/blood ; Ischemia/complications ; Ischemia/drug therapy* ; Ischemia/immunology ; Ischemia/pathology ; Macrophages/drug effects ; Macrophages/immunology ; Mice ; Mice, Inbred C57BL ; Muscle, Skeletal/blood supply* ; Neovascularization, Physiologic/drug effects ; Recovery of Function ; Regional Blood Flow/drug effects ; Signal Transduction/drug effects ; Taurochenodeoxycholic Acid/pharmacology* ; Time Factors
Endoplasmic reticulum (ER) stress and inflammation are important mechanisms that underlie many of the serious consequences of type II diabetes. However, the role of ER stress and inflammation in impaired ischaemia-induced neovascularization in type II diabetes is unknown. We studied ischaemia-induced neovascularization in the hind-limb of 4-week-old db - /db- mice and their controls treated with or without the ER stress inhibitor (tauroursodeoxycholic acid, TUDCA, 150 mg/kg per day) and interleukin-1 receptor antagonist (anakinra, 0.5 µg/mouse per day) for 4 weeks. Blood pressure was similar in all groups of mice. Blood glucose, insulin levels, and body weight were reduced in db - /db- mice treated with TUDCA. Increased cholesterol and reduced adiponectin in db - /db- mice were restored by TUDCA and anakinra treatment. ER stress and inflammation in the ischaemic hind-limb in db - /db- mice were attenuated by TUDCA and anakinra treatment. Ischaemia-induced neovascularization and blood flow recovery were significantly reduced in db - /db- mice compared to control. Interestingly, neovascularization and blood flow recovery were restored in db - /db- mice treated with TUDCA or anakinra compared to non-treated db - /db- mice. TUDCA and anakinra enhanced eNOS-cGMP, VEGFR2, and reduced ERK1/2 MAP-kinase signalling, while endothelial progenitor cell number was similar in all groups of mice. Our findings demonstrate that the inhibition of ER stress and inflammation prevents impaired ischaemia-induced neovascularization in type II diabetic mice. Thus, ER stress and inflammation could be potential targets for a novel therapeutic approach to prevent impaired ischaemia-induced vascular pathology in type II diabetes.
Files in This Item:
T201206217.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Physiology (생리학교실) > 1. Journal Papers
Yonsei Authors
Choi, Soo Kyoung(최수경) ORCID logo https://orcid.org/0000-0002-7115-6358
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.